Drugs Health Pharma

GSK to pay $1 billion to acquire exclusive rights for J&J hepatitis B therapy

 HQ Team November 1, 2023: GSK, a British pharmaceutical company, will pay $1 billion to Johnson & Johnson for transferring exclusive global rights.

Read More
Drugs Health Pharma

AstraZeneca inks $245 million deal with Cellectis for rare diseases

HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.

Read More
Drugs Medical Pharma

Clovibactin: A novel antibiotic with greater resistance

HQ Team November 1, 2023: A collaboration between the University of Bonn, Utrecht University, and Northeastern University in Boston, alongside NovoBiotic Pharmaceuticals, has.

Read More
Drugs Health Pharma

NIH researchers find 3,000 new brain cells, create ‘most detailed’ atlas

HQ Team November 1, 2023: The US’s medical research agency has discovered more than 3,000 new types of brain cells in different clusters.

Read More
Drugs Medical Pharma

FDA approves Santhera’s Agamree for Duchenne muscular dystrophy

HQ team October 31, 2023: The US Food and Drug Administration (FDA) has given the green light to Santhera Pharmaceuticals’ drug, Agamree (vamorolone),.

Read More
Drugs Health Pharma

FDA warns against use of certain OTC eye drop products

HQ Team October 31, 2023: The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due.

Read More
Drugs Health Pharma

Opinion: ‘I want to press the area with a hot iron box’: Shingles patient

By Dr K. Leelamoni October 31, 2023: During an annual family temple festival, celebrated at my ancestral home in the southern Indian state.

Read More
Drugs Health Medical Pharma

GSK’s Jemperli shows promise in treating endometrial cancer

HQ Team October 30, 2023: GSK plc has announced significant findings from a phase III trial trial for Jemperli (dostarlimab), a potential treatment for.

Read More
Drugs Health Medical Pharma

Gene therapy cure for sickle cell awaits advisory approval

HQ Team October 28, 2023: Advisers to the Food and Drug Administration (FDA) are set to review a gene therapy for sickle cell.

Read More
Health Medical Pharma

Study says little sugar in tea, coffee does not pose health risks

HQ Team October 28, 2023: A recent study conducted by a team of researchers from Denmark, the Netherlands, and the United Kingdom challenges.

Read More